🧬 Receptor activity
| Target | Action | Affinity | Source | |
|---|---|---|---|---|
| Cannabinoid receptor 1 (CNR1) | Agonist | — | DRUGCENTRAL | TargetCannabinoid receptor 1 (CNR1) ActionAgonist Affinity— SourceDRUGCENTRAL |
| Prostaglandin G/H synthase 2 (PTGS2) | Inhibitor | 4.31 IC50 | DRUGCENTRAL | TargetProstaglandin G/H synthase 2 (PTGS2) ActionInhibitor Affinity4.31 IC50 SourceDRUGCENTRAL |
| Transient receptor potential cation channel subfamily V member 1 (TRPV1) | Opener | — | DRUGCENTRAL | TargetTransient receptor potential cation channel subfamily V member 1 (TRPV1) ActionOpener Affinity— SourceDRUGCENTRAL |
| Arachidonate 15-lipoxygenase (ALOX15) | — | 4.547 IC50 | DRUGCENTRAL | TargetArachidonate 15-lipoxygenase (ALOX15) Action— Affinity4.547 IC50 SourceDRUGCENTRAL |
| Arachidonate 5-lipoxygenase-activating protein (ALOX5AP) | — | 4.36 IC50 | DRUGCENTRAL | TargetArachidonate 5-lipoxygenase-activating protein (ALOX5AP) Action— Affinity4.36 IC50 SourceDRUGCENTRAL |
| Carbonic anhydrase 1 (CA1) | — | 5 Ki | DRUGCENTRAL | TargetCarbonic anhydrase 1 (CA1) Action— Affinity5 Ki SourceDRUGCENTRAL |
| Carbonic anhydrase 12 (CA12) | — | 5.39 Ki | DRUGCENTRAL | TargetCarbonic anhydrase 12 (CA12) Action— Affinity5.39 Ki SourceDRUGCENTRAL |
| Carbonic anhydrase 13 (Ca13) | — | 4.52 Ki | DRUGCENTRAL | TargetCarbonic anhydrase 13 (Ca13) Action— Affinity4.52 Ki SourceDRUGCENTRAL |
| Carbonic anhydrase 14 (CA14) | — | 4.97 Ki | DRUGCENTRAL | TargetCarbonic anhydrase 14 (CA14) Action— Affinity4.97 Ki SourceDRUGCENTRAL |
| Carbonic anhydrase 15 (Ca15) | — | 5.03 Ki | DRUGCENTRAL | TargetCarbonic anhydrase 15 (Ca15) Action— Affinity5.03 Ki SourceDRUGCENTRAL |
| Carbonic anhydrase 2 (CA2) | — | 5.21 Ki | DRUGCENTRAL | TargetCarbonic anhydrase 2 (CA2) Action— Affinity5.21 Ki SourceDRUGCENTRAL |
| Carbonic anhydrase 3 (CA3) | — | 5.15 Ki | DRUGCENTRAL | TargetCarbonic anhydrase 3 (CA3) Action— Affinity5.15 Ki SourceDRUGCENTRAL |
| Carbonic anhydrase 4 (CA4) | — | 4.94 Ki | DRUGCENTRAL | TargetCarbonic anhydrase 4 (CA4) Action— Affinity4.94 Ki SourceDRUGCENTRAL |
| Carbonic anhydrase 7 (CA7) | — | 5.04 Ki | DRUGCENTRAL | TargetCarbonic anhydrase 7 (CA7) Action— Affinity5.04 Ki SourceDRUGCENTRAL |
| Carbonic anhydrase 9 (CA9) | — | 4.15 Ki | DRUGCENTRAL | TargetCarbonic anhydrase 9 (CA9) Action— Affinity4.15 Ki SourceDRUGCENTRAL |
| Myoglobin (MB) | — | 5.64 IC50 | DRUGCENTRAL | TargetMyoglobin (MB) Action— Affinity5.64 IC50 SourceDRUGCENTRAL |
| Nuclear receptor subfamily 1 group I member 3 (NR1I3) | — | — | DRUGCENTRAL | TargetNuclear receptor subfamily 1 group I member 3 (NR1I3) Action— Affinity— SourceDRUGCENTRAL |
External links
PubChem 1983 ↗CAS 103-90-2 ↗KEGG C06804 ↗ChEBI CHEBI:46195 ↗ChEMBL CHEMBL112 ↗KEGG D00217 ↗DrugBank DB00316 ↗NIH ↗NIH ↗NIH ↗NIH ↗NIH ↗NIH ↗ChemSpider ↗ChEBI/ChEMBL ↗ChEBI/ChEMBL ↗Guide to Pharmacology ↗NIH ↗NIH ↗NIH ↗NIH ↗DrugBank ↗ChEBI/ChEMBL ↗NIH ↗NIH ↗NIH ↗NIH ↗NIH ↗NIH ↗NIH ↗NIH ↗NIH ↗NIH ↗CAS 147630-09-9 ↗CAS 1693-37-4 ↗CAS 17194-82-0 ↗CAS 24424-99-5 ↗CAS 3070-86-8 ↗CAS 462631-86-3 ↗CAS 60902-28-5 ↗CAS 64315-36-2 ↗CAS 8055-08-1 ↗PsychonautWiki ↗Erowid ↗Experience reports (PiHKAL) ↗Experience reports (TiHKAL) ↗
Source: DrugCentral — Paracetamol ↗
Fact-sheets from PsychonautWiki. Harm-reduction reference only — not medical advice.